Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uricoqing is a traditional Chinese medicine (TCM) formulation, most commonly available as "Uricoqing granule." It is used in China for the management of gout and hyperuricemia. The product is typically administered as part of a sequential or staged treatment regimen for gout, often in combination with other TCM products such as Tongfengxiaotong granule. While the precise herbal composition and mechanism of action are not detailed in Western medical literature, TCM formulations like Uricoqing are generally believed to work by promoting uric acid excretion, reducing inflammation, and alleviating pain associated with gout. Clinical studies have been conducted at institutions such as Yunnan Hospital of Traditional Chinese Medicine[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Uricoqing.